Overview

Treatment of Subarachnoid Hemorrhage With Human Albumin

Status:
Terminated
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the tolerability and safety of 25 percent human albumin therapy in patients with subarachnoid hemorrhage.
Phase:
N/A
Details
Lead Sponsor:
Baylor College of Medicine
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)